Hrt Financial LP Amphastar Pharmaceuticals, Inc. Transaction History

Hrt Financial LP

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$42.85 - $63.45 $797,352 - $1.18 Million	18,608 New	18,608 $817,000
Q3 2023 Nov 13, 2023	BUY	$45.51 - $65.0 $183,314 - $261,820	4,028 Added 66.81%	10,057 $462,000
Q2 2023 Aug 11, 2023	SELL	$35.77 - $58.38 $927,086 - $1.51 Million	-25,918 Reduced 81.13%	6,029 $346,000
Q1 2023 May 12, 2023	BUY	$27.99 - $37.92 $398,969 - $540,511	14,254 Added 80.56%	31,947 $1.2 Million
Q4 2022 Feb 10, 2023	BUY	$27.93 - $31.27 $494,165 - $553,260	17,693 New	17,693 $495,000
Q2 2022 Aug 12, 2022	BUY	$29.79 - $42.29 $367,608 - $521,858	12,340 New	12,340 $429,000
Q4 2021 Feb 14, 2022	SELL	$18.14 - $23.29 $259,674 - $333,396	-14,315 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$17.83 - $21.49 $387,499 - $467,042	-21,733 Reduced 60.29%	14,315 $272,000
Q2 2021 Aug 16, 2021	BUY	$17.11 - $20.92 $616,781 - $754,124	36,048 New	36,048 $726,000
Q3 2020 Nov 13, 2020	SELL	$17.99 - $22.22 $209,655 - $258,951	-11,654 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$14.25 - $22.46 $166,069 - $261,748	11,654 New	11,654 $261,000

280

36.7M

74.3K

22.3K

Ticker AMPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,015,200
Market Cap $1.64B
Description
Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.